Corporate Updates
Kalbe Farma (KLBF IJ): KTA from semi-annual analyst meeting
Kalbe Farma (KLBF IJ)
Analyst: Anindya Saraswati
Not rated
KTA from semi-annual analyst meeting
• Distribution segment booked the strongest growth
• Pharmaceutical margin was under pressure
• Grew selectively
• Potential benefit from tax incentive
• Valuation